Professor and Founding Chair, Dept of Immunology,
Director, Institute of Neuro-Immune Pharmacology,
FIU College of Medicine Associate Dean, Bio. Med. Res,
Florida International University
Dr. Nair and his colleagues discovered the suppressor factor in cancer serum (1978) and first reported that intravenous drug users manifest low natural killer cell activity (1986) and morphine induces apoptosis of normal lymphocytes (1997). In 1988, Dr. Nair reported for the first time (PNAS) that HIV recombinant purified gene product possess significant biological activities. His original reports that cocaine increases the sensitivity to HIV infection by increasing the HIV co-receptors and methamphetamine exacerbates the HIV replication in dendritic cells had a profound effect on the role of these drugs on HIV disease progression. His recent research mainly involves the role of different drugs of abuses such as alcohol, morphine, cocaine and methamphetamine on neuro-AIDS and therapeutic approach to control Neuro-AIDS by specific drug targeting to brain using nanotechnology. Dr. Nair is the first FIU researcher to earn a prestigious MERIT Award from the National Institutes of Health recognizing outstanding competence and productivity in research (2008-2018). Dr. Nair is also the recipient of University of Michigan Distinguished Research Scientist Award (1990), Exceptional Research Scholar Award from State University of New York (2005), Excellence in Faculty Scholarship Award from FIU (2008), Presidential Leadership Operational Excellence Award from FIU in 2009 and FIU’s Top Research Scholar Award in 2010. Dr. Nair has published more than 100 papers as first and/or senior author, mentored more than 50 undergraduate, graduate, postdoctoral fellows, high school and minority students, served in various committees, organized various national and international conferences, chaired number of scientific sessions and served in various NIH study sections committees as chair/ member since 1980. His research is currently supported with four major NIH grants.